# Safety and Reactogenicity Trial of Vaccine for the Prevention of Infections Caused by Haemophilus Influenzae Type b

> **NCT05401305** · PHASE1 · COMPLETED · sponsor: **St. Petersburg Research Institute of Vaccines and Sera** · enrollment: 60 (actual)

## Conditions studied

- Haemophilus Influenzae Infection
- Vaccines

## Interventions

- **BIOLOGICAL:** Vaccine for the prevention of infections caused by Haemophilus influenza type b
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT05401305
- **Lead sponsor:** St. Petersburg Research Institute of Vaccines and Sera
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-14
- **Primary completion:** 2020-03-30
- **Final completion:** 2020-06-17
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2022-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05401305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05401305, "Safety and Reactogenicity Trial of Vaccine for the Prevention of Infections Caused by Haemophilus Influenzae Type b". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05401305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*